Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy

Abstract

Abstract Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression‐free survival without the adverse effects of steroid‐based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.

Keywords

• curcumin
• dexamethasone intolerance
• multiple myeloma